Oncotelic Therapeutics OTLC
OTC OTLC
$0.01 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Oncotelic Therapeutics (OTLC) FCF Margin (2012 - 2026)

Updated

Oncotelic Therapeutics (OTLC) reported FCF Margin of -1887.21% for FY2023.

Analysis

Oncotelic Therapeutics (OTLC) FCF Margin (2012 - 2026) Analysis & Trends

Dating back to FY2012, Oncotelic Therapeutics' FCF Margin record includes 5 years.

  • FCF Margin has a three-year change of -1725.68 percentage points (FY2020 to FY2023).
  • The FY2023 figure ranks as the lowest annual FCF Margin since FY2013.
  • According to Business Quant data, FCF Margin came in at -886.89% in FY2021 (-725.36 pp) and -161.53% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 25.03%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 41.97%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 30.51%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 52.85%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 35.25%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 57.81%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 28.96%
10 Oncotelic Therapeutics 5.77 Mn 4.94 Mn - -36.88%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.88%
Sep 30, 2023 -355.50%
Mar 31, 2021 -250.30%
Jun 30, 2020 16.25%
Mar 31, 2020 9.23%
Sep 30, 2013 -1,609.47%
Dec 31, 2012 -4,457.14%
Mar 31, 2012 -2,014.91%
API Access

Oncotelic Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=OTLC&period=max&api_key=YOUR_API_KEY